°æ±¸ »ý¹°Á¦Á¦ ½ÃÀå : ¾àÁ¦ Ŭ·¡½ºº°, ÀûÀÀ Áúȯº°, À¯Åë ä³Îº°, Áö¿ªº°
Oral Biologics Market, By Drug Class, By Disease Indication (Diabetes, Hyperoxaluria, Acromegaly, Irritable Bowel Syndrome & Chronic Idiopathic Constipation, Others ), By Distribution channel, By Geography
»óǰÄÚµå : 1358081
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2023³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,354,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,884,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,120,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ °æ±¸ »ý¹°Á¦Á¦ ½ÃÀåÀº 2023³â¿¡´Â 26¾ï 2,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, ¿¹Ãø ±â°£ Áß(2023-2030³â) 35.4%ÀÇ CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸®Æ÷Æ® ´ë»ó ¹üÀ§ ¸®Æ÷Æ® »ó¼¼
±âÁسâ 2022³â 2023³â ½ÃÀå ±Ô¸ð 26¾ï 2,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023-2030
¿¹Ãø ±â°£ CAGR 35.40% 2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø 218¾ï 4,000¸¸ ´Þ·¯
¼¼°èÀÇ °æ±¸ »ý¹°Á¦Á¦ ½ÃÀå Á¡À¯À²(%), ¾àÁ¦ À¯Çüº°, 2023³â
Oral Biologics Market-IMG1

°æ±¸¿ë »ý¹°ÇÐÀû Á¦Á¦´Â ´Ü¹éÁú, Ç×ü µî »ý¹°ÇÐÀû ±â¿øÀ» °¡Áö°í ÀÖÀ¸¸ç, Áֻ簡 ¾Æ´Ñ °æ±¸(Á¤Á¦³ª ĸ½¶ ÇüÅÂ)·Î Åõ¿©µÇ´Â ÀǾàǰÀÇ ¹üÁÖ¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ ºÐ¾ß´Â ´Ù¾çÇÑ Ä¡·á ¿µ¿ª¿¡¼­ Ä¡·á ȯ°æÀ» º¯È­½Ãų ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖÀ¸¸ç, ¸¹Àº °ü½É°ú ÅõÀÚ°¡ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. °æ±¸¿ë »ý¹°ÇÐÀû Á¦Á¦ÀÇ ÀáÀçÀû ¿ëµµ´Â ±¤¹üÀ§ÇÑ Ä¡·á ¿µ¿ª¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù. ·ù¸¶Æ¼½º °üÀý¿°, ¿°Áõ¼º Àå Áúȯ, ´Ù¹ß¼º °æÈ­Áõ°ú °°Àº ÀÚ°¡¸é¿ª ÁúȯÀº ´ëÇ¥ÀûÀΠǥÀû Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ °æ±¸¿ë »ý¹°ÇÐÀû Á¦Á¦´Â ´ç´¢º´, ¾Ï, Èñ±Í À¯Àü¼º ÁúȯÀÇ Ä¡·á¿¡µµ À¯¸ÁÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ü¿ë¼ºÀº °Å´ë Á¦¾àȸ»ç¿Í Çõ½ÅÀû ½ºÅ¸Æ®¾÷ ¸ðµÎ ÁÖ¸ñÇϰí ÀÖÀ¸¸ç, ½ÃÀåÀÇ Çõ½Å°ú Çù·ÂÀ» ÃËÁøÇÏ´Â °æÀï ±¸µµ¸¦ Á¶¼ºÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚ ÆíÀǼº°ú ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ °æ±¸¿ë »ý¹°ÇÐÀû Á¦Á¦´Â ±âÁ¸ ÁÖ»çÁ¦ ´ë½Å À¯¸ÁÇÑ ´ë¾ÈÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÁÖ¿ä ½ÃÀå Âü¿©ÀÚµéÀº ¼¼°è »ç¾÷ È®ÀåÀ» À§ÇØ ½ÅÁ¦Ç° Ãâ½Ã¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 1¿ù ¼¼°è Á¦¾à»ç ³ëº¸ ³ëµð½ºÅ©´Â ´ç´¢º´ Ä¡·á¸¦ À§ÇÑ °æ±¸¿ë GLP-1 ¼ö¿ëü À¯»çü(GLP-1 RA)¸¦ Ãâ½ÃÇßÀ¸¸ç, °æ±¸¿ë GLP-1 ¼ö¿ëü À¯»çü(GLP-1 RA)°¡ Ãâ½ÃµÇ±â Àü¿¡´Â GLP-1 ¼ö¿ëü À¯»çü(GLP-1 RA)´Â ÁÖ»çÁ¦·Î¸¸ »ç¿ëµÇ¾ú½À´Ï´Ù. 1 RA)´Â ÁÖ»çÁ¦¸¸ Á¸ÀçÇßÀ¸¸ç, °æ±¸¿ë GLP-1 RA°¡ Ãâ½ÃµÈ ÀûÀº ¾ø¾ú½À´Ï´Ù. °æ±¸¿ë ¼¼¸¶±Û·çƼµå´Â GLP-1 RA ¼¼¸¶±Û·çƼµå¿Í Èí¼ö ÃËÁøÁ¦ SNACÀÇ º¹ÇÕÁ¦·Î, ´Ù¸¥ ÆéƼµåó·³ À§Àå¿¡¼­ ºÐÇØµÇ´Â °ÍÀ» ¹æÁöÇϰí Èí¼ö¸¦ °³¼±ÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ °æ±¸ »ý¹°Á¦Á¦ ½ÃÀå - ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°ÁõÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ °æ±¸ »ý¹°Á¦Á¦ ½ÃÀå : ¾àÁ¦ Ŭ·¡½ºº°, 2018-2030³â

Á¦6Àå ¼¼°èÀÇ °æ±¸ »ý¹°Á¦Á¦ ½ÃÀå : ÀûÀÀ Áúȯº°, 2018-2030³â

Á¦7Àå ¼¼°èÀÇ °æ±¸ »ý¹°Á¦Á¦ ½ÃÀå : À¯Åë ä³Îº°, 2018-2030³â

Á¦8Àå ¼¼°èÀÇ °æ±¸ »ý¹°Á¦Á¦ ½ÃÀå : Áö¿ªº°, 2018-2030³â

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¼½¼Ç

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global oral biologics market is estimated to be valued at US$ 2.62 Bn in 2023 and is expected to exhibit a CAGR of 35.4% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 2.62 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 35.40% 2030 Value Projection: US$ 21.84 Bn
Global Oral Biologics Market Share (%), By Drug Type, 2023
Oral Biologics Market - IMG1

Oral biologics refers to a category of medications that are biologically derived, like proteins or antinodies, and are administered orally (in the form of pills and capsules) rather than through injections. This segment has garnered significant attention and investment due to its potential to revolutionize the treatment landscape across various therapeutic areas. The potential applications of oral biologics span a wide range of therapeutic areas. Autoimmune disorders, including rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis, are among the prominent targets. Additionally, oral biologics hold promise for treating diabetes, cancer, and rare genetic diseases. This versatility has attracted attention from both pharmaceutical giants and innovative startups, fostering a competitive landscape that drives innovation and collaboration in the market. Further, patient convenience and technological advancements have positioned oral biologics as a promising alternative to traditional injectable biologics, which is expected to drive market growth in the forecast years.

Market Dynamics

The key market players are focused on the launch of new products in the market to expand their business globally, and this is expected to boost the growth of the market over the forecast period. For instance, in January 2022, Novo Nordisk, a global pharmaceutical company, launched the GLP-1 receptor analogue (GLP-1 RA) in an oral pill formulation for the treatment of diabetes. Before the launch of the GLP-1 receptor analogue (GLP-1 RA) oral pill, GLP-1 receptor analogue (GLP-1 RA) was only available in injection form. A GLP-1 RA has never before been created in an oral formulation. In order to prevent it from degrading in the stomach like other peptides do and to improve absorption, oral semaglutide is a co-formulation of GLP-1RA semaglutide and the absorption enhancer SNAC.

Key features of the study:

Oral Biologics Market Detailed Segmentation:

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Oral Biologics Market-COVID-19 Impact Analysis

5. Global Oral Biologics Market, By Drug Class, 2018-2030, (US$ Bn)

6. Global Oral Biologics Market, By Disease Indication, 2018-2030, (US$ Bn)

7. Global Oral Biologics Market, By Distribution Channel, 2018-2030, (US$ Bn)

8. Global Oral Biologics Market, By Region, 2018-2030, (US$ Bn)

9. Competitive Landscape

10. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â